Our result might be linked to higher proportions of AD cases with depression as it is important to note that we did not find any differences in AD neuropathology when considering only the AD or only the control group and neither tau nor amyloid burden significantly predicted depression in controls. The gene discussed is MAPT; the disease is depressive symptom measurement.